A detailed history of Old National Bancorp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Old National Bancorp holds 19,151 shares of GILD stock, worth $1.62 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
19,151
Previous 21,304 10.11%
Holding current value
$1.62 Million
Previous $1.56 Million 15.83%
% of portfolio
0.03%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$63.15 - $72.88 $135,961 - $156,910
-2,153 Reduced 10.11%
19,151 $1.31 Million
Q1 2024

Apr 15, 2024

SELL
$71.58 - $87.29 $101,214 - $123,428
-1,414 Reduced 6.22%
21,304 $1.56 Million
Q4 2023

Feb 01, 2024

SELL
$73.27 - $83.09 $58,762 - $66,638
-802 Reduced 3.41%
22,718 $1.84 Million
Q3 2023

Nov 17, 2023

SELL
$73.94 - $80.67 $47,099 - $51,386
-637 Reduced 2.64%
23,520 $1.76 Million
Q2 2023

Jul 25, 2023

BUY
$76.01 - $86.7 $18,014 - $20,547
237 Added 0.99%
24,157 $1.86 Million
Q1 2023

Apr 19, 2023

BUY
$77.31 - $88.08 $130,344 - $148,502
1,686 Added 7.58%
23,920 $1.98 Million
Q4 2022

Feb 03, 2023

SELL
$62.32 - $89.47 $4,736 - $6,799
-76 Reduced 0.34%
22,234 $1.91 Million
Q3 2022

Feb 17, 2023

BUY
$59.54 - $68.01 $4,525 - $5,168
76 Added 0.34%
22,310 $1.38 Million
Q3 2022

Nov 08, 2022

BUY
$59.54 - $68.01 $71,983 - $82,224
1,209 Added 5.73%
22,310 $1.38 Million
Q2 2022

Jul 25, 2022

BUY
$57.72 - $65.01 $852,813 - $960,522
14,775 Added 233.56%
21,101 $1.31 Million
Q1 2022

May 09, 2022

BUY
$57.92 - $72.58 $4,923 - $6,169
85 Added 1.36%
6,326 $376,000
Q4 2021

Jan 25, 2022

SELL
$64.88 - $73.64 $11,483 - $13,034
-177 Reduced 2.76%
6,241 $453,000
Q3 2021

Oct 25, 2021

BUY
$67.69 - $73.03 $13,199 - $14,240
195 Added 3.13%
6,418 $449,000
Q2 2021

Jul 26, 2021

SELL
$63.47 - $69.35 $717,718 - $784,209
-11,308 Reduced 64.5%
6,223 $429,000
Q1 2021

Apr 21, 2021

SELL
$60.0 - $68.46 $120 - $136
-2 Reduced 0.01%
17,531 $1.13 Million
Q4 2020

Jan 19, 2021

SELL
$56.65 - $64.55 $11,330 - $12,910
-200 Reduced 1.13%
17,533 $1.02 Million
Q3 2020

Oct 29, 2020

SELL
$62.1 - $78.08 $68,682 - $86,356
-1,106 Reduced 5.87%
17,733 $1.12 Million
Q2 2020

Jul 27, 2020

SELL
$72.34 - $84.0 $9,259 - $10,752
-128 Reduced 0.67%
18,839 $1.45 Million
Q1 2020

Apr 24, 2020

SELL
$62.63 - $80.22 $75,093 - $96,183
-1,199 Reduced 5.95%
18,967 $1.42 Million
Q4 2019

Jan 16, 2020

BUY
$61.62 - $67.78 $41,038 - $45,141
666 Added 3.42%
20,166 $1.31 Million
Q3 2019

Oct 22, 2019

SELL
$62.51 - $69.0 $101,891 - $112,470
-1,630 Reduced 7.71%
19,500 $1.24 Million
Q2 2019

Jul 15, 2019

SELL
$61.87 - $69.38 $309,968 - $347,593
-5,010 Reduced 19.17%
21,130 $1.43 Million
Q1 2019

Apr 30, 2019

SELL
$62.53 - $70.05 $241,928 - $271,023
-3,869 Reduced 12.89%
26,140 $1.7 Million
Q4 2018

Jan 31, 2019

BUY
$60.54 - $79.0 $77,127 - $100,646
1,274 Added 4.43%
30,009 $1.88 Million
Q3 2018

Oct 26, 2018

SELL
$71.28 - $78.92 $50,323 - $55,717
-706 Reduced 2.4%
28,735 $2.22 Million
Q2 2018

Jul 26, 2018

BUY
$64.88 - $75.68 $1.91 Million - $2.23 Million
29,441 New
29,441 $2.09 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $106B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Old National Bancorp Portfolio

Follow Old National Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

News

Stay updated on Old National Bancorp with notifications on news.